3 Stocks Due for a Major Rally in July

The article argues big-tech pullbacks are overdone: Microsoft shares are down ~20% YTD (and ~30% from their all-time high) despite last-quarter revenue +18% and diluted EPS +23%, with its AI annual recurring run rate at $37B (+123% YoY) and valuation at ~19x projected FY2027 earnings. Meta trades at ~17x forward earnings versus the S&P 500 at ~21.5x, despite Q1 revenue growth of ~33%, and is framed as “due for a rally.” Nvidia is up only ~3% YTD but is positioned for upside as AI hyperscaler capex is expected to exceed $1T next year (vs $650B this year), with forward valuation described as ~21.5x now but ~15x using next year’s earnings.

Analysis

The market is not really debating whether these franchises are good businesses; it is debating how much of the AI spend cycle will convert into durable free cash flow versus transient capex. That distinction matters because the first leg of the trade has already happened: multiple compression on “high-quality growth” can persist even when reported revenue is still strong if investors think depreciation, power, and model-training costs are front-loaded.

For MSFT and META, the second-order issue is not revenue quality but monetization latency. If AI features improve engagement or cloud attach rates, the payoff likely shows up over several quarters, while the cash outlay is immediate; that creates a window where the stocks can look cheap and still underperform. NVDA is the cleanest expression of the capex cycle, but it is also the most exposed to any slowdown in hyperscaler order cadence or a mix shift toward custom silicon; the stock needs continued upward revisions, not just a low forward multiple, to sustain outperformance.

Contrarian take: the consensus may be underestimating how sticky the AI infrastructure buildout is over the next 6-12 months, which favors NVDA and the broader equipment/networking stack, but overestimating how quickly META can translate AI into ad yield. If the next catalyst round shows only incremental monetization and rising capex, the current "cheap" setup can stay cheap for longer than bulls expect. Falsifiers are simple: any Azure/data-center growth deceleration for MSFT, a capex guide-up without offsetting ad monetization for META, or a guide-down on NVDA hyperscaler demand.

Key Decisions for Investors

• Long NVDA on 3-6 month weakness only; use a 10-15% pullback as entry for a continuation trade into the next hyperscaler capex print. Risk/reward is attractive if next-year EPS revisions keep rising, but invalidate if data-center growth or order visibility softens.
• Prefer MSFT over META on a relative basis: long MSFT / short META for the next 1-3 months if you want lower execution risk and less regulatory/advertising cyclicality. The pair works if AI monetization remains slow and capex keeps absorbing cash flow.
• Buy a modest NVDA call spread into the next earnings/capex commentary window rather than outright stock if you want defined risk. The trade only works if the market starts to price in another revision cycle; cut if the implied growth trajectory stalls.
• Avoid chasing META on valuation alone; wait for evidence that AI spend is improving ad ROI rather than just increasing expenses. If the next quarter shows higher capex with no margin leverage, the stock can de-rate further despite the low multiple.
• Watch AVGO, ANET, and SMCI as second-order beneficiaries of a sustained AI buildout; if NVDA pauses but those names keep acting well, it suggests capex breadth is still expanding and the broader AI trade is not exhausted.